{"pmid":32376581,"pmcid":"PMC7167308","title":"[An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19].","text":["[An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19].","OBJECTIVE: To identify the biomarkers as early warning signals for severe COVID-19. METHODS: We retrospectively analyzed the clinical data of 63 patients with COVID- 19 from Hubei Provincial Hospital of Integrated Chinese and Western Medicine, including 32 moderate cases and 31 severe cases. The demographic data, underlying diseases, clinical manifestations and laboratory test results were compared between the two groups. Logistic regression analysis was performed to identify the factors that predicted the severity of COVID-19. The receiver- operating characteristic curve (ROC) of neutrophil/lymphocyte ratio (NLR) was calculated, and the area under the curve (AUC) was determined to estimate the optimal threshold of NLR for predicting severe cases of COVID-19. RESULTS: The patients with moderate and server COVID-19 showed significant differences in the rate of diabetes, NLR, serum amyloid A (SSA), C-reactive protein (CRP) and serum albumin (ALB) levels (P < 0.05). The co- morbidity of diabetes, NLR, SSA and CRP were found to positively correlate and ALB to inversely correlate with the severity of COVID-19 (P < 0.05). Multivariate logistic regression analysis showed that NLR was an independent risk factor for severe COVID-19 (OR=1.264, 95% CI: 1.046-1.526, P=0.015) with an AUC of 0.831 (95% CI: 0.730-0.932), an optimal diagnostic threshold of 4.795, a sensitivity of 0.839, and a specificity of 0.750. CONCLUSIONS: An increased NLR can serve as an early warning signal of severe COVID-19.","Nan Fang Yi Ke Da Xue Xue Bao","Xia, Xintian","Wen, Minyong","Zhan, Shaofeng","He, Jing","Chen, Weitao","32376581"],"abstract":["OBJECTIVE: To identify the biomarkers as early warning signals for severe COVID-19. METHODS: We retrospectively analyzed the clinical data of 63 patients with COVID- 19 from Hubei Provincial Hospital of Integrated Chinese and Western Medicine, including 32 moderate cases and 31 severe cases. The demographic data, underlying diseases, clinical manifestations and laboratory test results were compared between the two groups. Logistic regression analysis was performed to identify the factors that predicted the severity of COVID-19. The receiver- operating characteristic curve (ROC) of neutrophil/lymphocyte ratio (NLR) was calculated, and the area under the curve (AUC) was determined to estimate the optimal threshold of NLR for predicting severe cases of COVID-19. RESULTS: The patients with moderate and server COVID-19 showed significant differences in the rate of diabetes, NLR, serum amyloid A (SSA), C-reactive protein (CRP) and serum albumin (ALB) levels (P < 0.05). The co- morbidity of diabetes, NLR, SSA and CRP were found to positively correlate and ALB to inversely correlate with the severity of COVID-19 (P < 0.05). Multivariate logistic regression analysis showed that NLR was an independent risk factor for severe COVID-19 (OR=1.264, 95% CI: 1.046-1.526, P=0.015) with an AUC of 0.831 (95% CI: 0.730-0.932), an optimal diagnostic threshold of 4.795, a sensitivity of 0.839, and a specificity of 0.750. CONCLUSIONS: An increased NLR can serve as an early warning signal of severe COVID-19."],"journal":"Nan Fang Yi Ke Da Xue Xue Bao","authors":["Xia, Xintian","Wen, Minyong","Zhan, Shaofeng","He, Jing","Chen, Weitao"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32376581","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.12122/j.issn.1673-4254.2020.03.06","keywords":["covid-19","neutrophil/lymphocyte ratio","warning signal"],"locations":["optimal"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666262687593529344,"score":9.490897,"similar":[{"pmid":32436996,"title":"The value of clinical parameters in predicting the severity of COVID-19.","text":["The value of clinical parameters in predicting the severity of COVID-19.","OBJECTIVE: To study the relationship between clinical indexes and the severity of coronavirus disease 2019 (COVID-19), and to explore its role in predicting the severity of COVID-19. METHODS: Clinical data of 443 patients with COVID-19 admitted to our hospital were retrospectively analyzed, which were divided into non-severe group (n=304) and severe group (n=139) according to their condition. Clinical indicators were compared between different groups. RESULTS: The differences in gender, age, the proportion of patients with combined heart disease, leukocyte, neutrophil-to-lymphocyte ratio (NLR), neutrophil, lymphocyte, platelet, D-dimer, C-reactive protein (CRP), procalcitonin, lactate dehydrogenase and albumin on admission between the two groups were statistically significant (p<0.05). Multivariate logistic regression analysis showed NLR and CRP were independent risk factors for severe COVID-19. Platelets were independent protective factors for severe COVID-19. Receiver Operating Characteristic (ROC) curve analysis demonstrated area under the curve (AUC) of NLR, platelet, CRP and combination was 0.737, 0.634, 0.734 and 0.774, respectively. CONCLUSIONS: NLR, CRP and platelets can effectively assess the severity of COVID-19, among which NLR is the best predictor of severe COVID-19, and the combination of three clinical indicators can further predict severe COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","Shang, Weifeng","Dong, Junwu","Ren, Yali","Tian, Ming","Li, Wei","Hu, Jianwu","Li, Yuanyuan","32436996"],"abstract":["OBJECTIVE: To study the relationship between clinical indexes and the severity of coronavirus disease 2019 (COVID-19), and to explore its role in predicting the severity of COVID-19. METHODS: Clinical data of 443 patients with COVID-19 admitted to our hospital were retrospectively analyzed, which were divided into non-severe group (n=304) and severe group (n=139) according to their condition. Clinical indicators were compared between different groups. RESULTS: The differences in gender, age, the proportion of patients with combined heart disease, leukocyte, neutrophil-to-lymphocyte ratio (NLR), neutrophil, lymphocyte, platelet, D-dimer, C-reactive protein (CRP), procalcitonin, lactate dehydrogenase and albumin on admission between the two groups were statistically significant (p<0.05). Multivariate logistic regression analysis showed NLR and CRP were independent risk factors for severe COVID-19. Platelets were independent protective factors for severe COVID-19. Receiver Operating Characteristic (ROC) curve analysis demonstrated area under the curve (AUC) of NLR, platelet, CRP and combination was 0.737, 0.634, 0.734 and 0.774, respectively. CONCLUSIONS: NLR, CRP and platelets can effectively assess the severity of COVID-19, among which NLR is the best predictor of severe COVID-19, and the combination of three clinical indicators can further predict severe COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Shang, Weifeng","Dong, Junwu","Ren, Yali","Tian, Ming","Li, Wei","Hu, Jianwu","Li, Yuanyuan"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32436996","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/jmv.26031","keywords":["covid-19","clinical characteristics","coronavirus disease 2019","novel coronavirus pneumonia"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667521393760141312,"score":449.71262},{"pmid":32407937,"title":"The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.","text":["The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.","OBJECTIVE: To investigate the clinical features of COVID-19 cases in Suzhou China. Biomarkers were screened out of hematological parameters for risk stratification. METHOD: Confirmed COVID-19 adult patients in Suzhou were included. The patient data was collected, and the results of laboratory examinations were compared between the mild/moderate and severe COVID-19 groups. A ROC was calculated to compare the diagnostic performance of candidate indexes, and dynamic levels of hematological indexes were compared between the two groups. RESULT: 75 patients were enrolled, with a mean age of 46.6+/-14years, and 45 patients were male. All patients were classified into two groups: the mild/moderate group and the severe group. WBC, neutrophil to lymphocyte ratio (NLR), D-dimer, and fibrinogen levels of the severe group were significantly higher (P<0.05) than the mild/moderate, and the lymphocyte was lower. The ROC test showed that the hematological parameters had a larger AUC than that of inflammatory factors. There was a significant difference in lymphocyte and fibrinogen levels between the two groups on day 1 (P<0.05). However, NLR of the severe group was higher than the mild/moderate on days 1, 4 and 14 (P<0.01), and so was D-dimer on days 1, 7 and 14 (P<0.05). CONCLUSION: The common COVID-19 abnormal hematological indexes on admission included hyperfibrinogenemia, lymphopenia, the elevation of D-dimer, and leukopenia, which were significantly different between the mild/moderate and severe COVID-19 groups. Furthermore, the dynamic change of NLR and D-dimer level can distinguish severe COVID-19 cases from the mild/moderate.","Thromb Res","Fu, Jianhong","Kong, Jindan","Wang, Wei","Wu, Meiying","Yao, Lin","Wang, Zhaoyue","Jin, Jun","Wu, Depei","Yu, Xin","32407937"],"abstract":["OBJECTIVE: To investigate the clinical features of COVID-19 cases in Suzhou China. Biomarkers were screened out of hematological parameters for risk stratification. METHOD: Confirmed COVID-19 adult patients in Suzhou were included. The patient data was collected, and the results of laboratory examinations were compared between the mild/moderate and severe COVID-19 groups. A ROC was calculated to compare the diagnostic performance of candidate indexes, and dynamic levels of hematological indexes were compared between the two groups. RESULT: 75 patients were enrolled, with a mean age of 46.6+/-14years, and 45 patients were male. All patients were classified into two groups: the mild/moderate group and the severe group. WBC, neutrophil to lymphocyte ratio (NLR), D-dimer, and fibrinogen levels of the severe group were significantly higher (P<0.05) than the mild/moderate, and the lymphocyte was lower. The ROC test showed that the hematological parameters had a larger AUC than that of inflammatory factors. There was a significant difference in lymphocyte and fibrinogen levels between the two groups on day 1 (P<0.05). However, NLR of the severe group was higher than the mild/moderate on days 1, 4 and 14 (P<0.01), and so was D-dimer on days 1, 7 and 14 (P<0.05). CONCLUSION: The common COVID-19 abnormal hematological indexes on admission included hyperfibrinogenemia, lymphopenia, the elevation of D-dimer, and leukopenia, which were significantly different between the mild/moderate and severe COVID-19 groups. Furthermore, the dynamic change of NLR and D-dimer level can distinguish severe COVID-19 cases from the mild/moderate."],"journal":"Thromb Res","authors":["Fu, Jianhong","Kong, Jindan","Wang, Wei","Wu, Meiying","Yao, Lin","Wang, Zhaoyue","Jin, Jun","Wu, Depei","Yu, Xin"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32407937","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.thromres.2020.05.006","keywords":["coronavirus disease 2019","d-dimer","neutrophil to lymphocyte ratio"],"locations":["Suzhou","China","Suzhou","hyperfibrinogenemia","lymphopenia","Suzhou","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666802845464133633,"score":411.4443},{"pmid":32434518,"title":"Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.","text":["Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.","BACKGROUND: Patients with critical illness due to infection with the 2019 coronavirus disease (COVID-19) show rapid disease progression to acute respiratory failure. The study aimed to screen the most useful predictive factor for critical illness caused by COVID-19. METHODS: The study prospectively involved 61 patients with COVID-19 infection as a derivation cohort, and 54 patients as a validation cohort. The predictive factor for critical illness was selected using LASSO regression analysis. A nomogram based on non-specific laboratory indicators was built to predict the probability of critical illness. RESULTS: The neutrophil-to-lymphocyte ratio (NLR) was identified as an independent risk factor for critical illness in patients with COVID-19 infection. The NLR had an area under receiver operating characteristic of 0.849 (95% confidence interval [CI], 0.707 to 0.991) in the derivation cohort and 0.867 (95% CI 0.747 to 0.944) in the validation cohort, the calibration curves fitted well, and the decision and clinical impact curves showed that the NLR had high standardized net benefit. In addition, the incidence of critical illness was 9.1% (1/11) for patients aged >/= 50 and having an NLR < 3.13, and 50% (7/14) patients with age >/= 50 and NLR >/= 3.13 were predicted to develop critical illness. Based on the risk stratification of NLR according to age, this study has developed a COVID-19 pneumonia management process. CONCLUSIONS: We found that NLR is a predictive factor for early-stage prediction of patients infected with COVID-19 who are likely to develop critical illness. Patients aged >/= 50 and having an NLR >/= 3.13 are predicted to develop critical illness, and they should thus have rapid access to an intensive care unit if necessary.","J Transl Med","Liu, Jingyuan","Liu, Yao","Xiang, Pan","Pu, Lin","Xiong, Haofeng","Li, Chuansheng","Zhang, Ming","Tan, Jianbo","Xu, Yanli","Song, Rui","Song, Meihua","Wang, Lin","Zhang, Wei","Han, Bing","Yang, Li","Wang, Xiaojing","Zhou, Guiqin","Zhang, Ting","Li, Ben","Wang, Yanbin","Chen, Zhihai","Wang, Xianbo","32434518"],"abstract":["BACKGROUND: Patients with critical illness due to infection with the 2019 coronavirus disease (COVID-19) show rapid disease progression to acute respiratory failure. The study aimed to screen the most useful predictive factor for critical illness caused by COVID-19. METHODS: The study prospectively involved 61 patients with COVID-19 infection as a derivation cohort, and 54 patients as a validation cohort. The predictive factor for critical illness was selected using LASSO regression analysis. A nomogram based on non-specific laboratory indicators was built to predict the probability of critical illness. RESULTS: The neutrophil-to-lymphocyte ratio (NLR) was identified as an independent risk factor for critical illness in patients with COVID-19 infection. The NLR had an area under receiver operating characteristic of 0.849 (95% confidence interval [CI], 0.707 to 0.991) in the derivation cohort and 0.867 (95% CI 0.747 to 0.944) in the validation cohort, the calibration curves fitted well, and the decision and clinical impact curves showed that the NLR had high standardized net benefit. In addition, the incidence of critical illness was 9.1% (1/11) for patients aged >/= 50 and having an NLR < 3.13, and 50% (7/14) patients with age >/= 50 and NLR >/= 3.13 were predicted to develop critical illness. Based on the risk stratification of NLR according to age, this study has developed a COVID-19 pneumonia management process. CONCLUSIONS: We found that NLR is a predictive factor for early-stage prediction of patients infected with COVID-19 who are likely to develop critical illness. Patients aged >/= 50 and having an NLR >/= 3.13 are predicted to develop critical illness, and they should thus have rapid access to an intensive care unit if necessary."],"journal":"J Transl Med","authors":["Liu, Jingyuan","Liu, Yao","Xiang, Pan","Pu, Lin","Xiong, Haofeng","Li, Chuansheng","Zhang, Ming","Tan, Jianbo","Xu, Yanli","Song, Rui","Song, Meihua","Wang, Lin","Zhang, Wei","Han, Bing","Yang, Li","Wang, Xiaojing","Zhou, Guiqin","Zhang, Ting","Li, Ben","Wang, Yanbin","Chen, Zhihai","Wang, Xianbo"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434518","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1186/s12967-020-02374-0","keywords":["2019-ncov","covid-19","model","nlr","prognosis","sars-cov"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667521393792647169,"score":361.67676},{"pmid":32445579,"title":"Prognostic value of C-reactive protein in patients with COVID-19.","text":["Prognostic value of C-reactive protein in patients with COVID-19.","BACKGROUND: Elevated serum C-reactive protein (CRP) level was observed in most patients with COVID-19. METHODS: Data of COVID-19 patients with clinical outcome in a designated hospital in Wuhan, China, were retrospectively collected and analyzed from Jan 30 to Feb 20, 2020. The prognostic value of admission CRP was evaluated in patients with COVID-19. RESULTS: Out of 298 patients enrolled, 84 died and 214 recovered. Most non-survivors tended to be males, old aged, or with chronic diseases. Compared to survivors, non-survivors showed significantly elevated white blood cell and neutrophil count, neutrophil to lymphocyte ratio (NLR), systemic immune-inflammation index (SII, defined by platelet count multiply by NLR), CRP, procalcitonin, and D-dimer, and decreased red blood cell, lymphocyte, and platelet count. Age, neutrophil count, platelet count, and CRP were identified as independent predictors of adverse outcome. The area under the receiver operating characteristic (ROC) curve (AUC) of CRP (0.896) was significantly higher than that of age (0.833), neutrophil count (0.820), and platelet count (0.678) in outcome prediction (all p<0.05). With a cut-off value of 41.4, CRP exhibited sensitivity 90.5%, specificity 77.6%, positive predictive value 61.3%, and negative predictive value 95.4%. Subgroup analysis revealed that CRP remained robust accuracy in adverse outcome prediction in patients with different disease severity (AUC 0.832, z=10.23, p<0.001; AUC 0.989, z=44.04, p<0.001). CRP was also an independent discriminator of severe/critical illness on admission (AUC 0.783, z=10.69, p<0.001). CONCLUSIONS: In patients with COVID-19, admission CRP correlated with disease severity and tended to be a good predictor of adverse outcome.","Clin Infect Dis","Luo, Xiaomin","Zhou, Wei","Yan, Xiaojie","Guo, Tangxi","Wang, Benchao","Xia, Hongxia","Ye, Lu","Xiong, Jun","Jiang, Zongping","Liu, Yu","Zhang, Bicheng","Yang, Weize","32445579"],"abstract":["BACKGROUND: Elevated serum C-reactive protein (CRP) level was observed in most patients with COVID-19. METHODS: Data of COVID-19 patients with clinical outcome in a designated hospital in Wuhan, China, were retrospectively collected and analyzed from Jan 30 to Feb 20, 2020. The prognostic value of admission CRP was evaluated in patients with COVID-19. RESULTS: Out of 298 patients enrolled, 84 died and 214 recovered. Most non-survivors tended to be males, old aged, or with chronic diseases. Compared to survivors, non-survivors showed significantly elevated white blood cell and neutrophil count, neutrophil to lymphocyte ratio (NLR), systemic immune-inflammation index (SII, defined by platelet count multiply by NLR), CRP, procalcitonin, and D-dimer, and decreased red blood cell, lymphocyte, and platelet count. Age, neutrophil count, platelet count, and CRP were identified as independent predictors of adverse outcome. The area under the receiver operating characteristic (ROC) curve (AUC) of CRP (0.896) was significantly higher than that of age (0.833), neutrophil count (0.820), and platelet count (0.678) in outcome prediction (all p<0.05). With a cut-off value of 41.4, CRP exhibited sensitivity 90.5%, specificity 77.6%, positive predictive value 61.3%, and negative predictive value 95.4%. Subgroup analysis revealed that CRP remained robust accuracy in adverse outcome prediction in patients with different disease severity (AUC 0.832, z=10.23, p<0.001; AUC 0.989, z=44.04, p<0.001). CRP was also an independent discriminator of severe/critical illness on admission (AUC 0.783, z=10.69, p<0.001). CONCLUSIONS: In patients with COVID-19, admission CRP correlated with disease severity and tended to be a good predictor of adverse outcome."],"journal":"Clin Infect Dis","authors":["Luo, Xiaomin","Zhou, Wei","Yan, Xiaojie","Guo, Tangxi","Wang, Benchao","Xia, Hongxia","Ye, Lu","Xiong, Jun","Jiang, Zongping","Liu, Yu","Zhang, Bicheng","Yang, Weize"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32445579","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1093/cid/ciaa641","keywords":["c-reactive protein","covid-2019","sars-cov-2","prognosis"],"locations":["Wuhan","China","neutrophil"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1667600475934949376,"score":355.75253},{"pmid":32458459,"title":"Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Patients with Coronavirus Disease 2019: A Retrospective Cross-sectional Study.","text":["Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Patients with Coronavirus Disease 2019: A Retrospective Cross-sectional Study.","OBJECTIVE: This retrospective study was designed to explore whether neutrophil to lymphocyte ratio (NLR) is a prognostic factor in patients with coronavirus disease 2019 (covid-19). METHODS: A cohort of patients with covid-19 admitted to the Tongren Hospital of Wuhan University from January 11, 2020 to March 3, 2020 was retrospectively analyzed. Patients with hematologic malignancy were excluded. The NLR was calculated by dividing the neutrophil count by the lymphocyte count. NLR values were measured at the time of admission. The primary outcome was all-cause in-hospital mortality. A multivariate logistic analysis was performed. RESULTS: 1004 patients with covid-19 were included in this study. The mortality rate was 4.0% (40 cases). The median age of nonsurvivors (68 years) was significantly older than survivors (62 years). Male sex was more predominant in nonsurvival group (27; 67.5%) than in the survival group (466; 48.3%). NLR value of nonsurvival group (median 49.06, IQR 25.71-69.70) was higher than that of survival group (median 4.11, IQR 2.44-8.12, P < 0.001). In multivariate logistic regression analysis, after adjusting for confounding factors, NLR > 11.75 was significantly correlated with all-cause in-hospital mortality (OR = 44.351, 95% CI = 4.627-425.088). CONCLUSIONS: These results suggest that the NLR at hospital admission is associated in-hospital mortality among patients with covid-19. Therefore, the NLR appears to be a significant prognostic biomarker of outcomes in critically ill patients with covid-19. However, further investigation is needed to validate this relationship with data collected prospectively. This article is protected by copyright. All rights reserved.","J Med Virol","Yan, Xisheng","Li, Fen","Wang, Xiao","Yan, Jie","Zhu, Fen","Tang, Shifan","Deng, Yingzhong","Wang, Hua","Chen, Rui","Yu, Zhili","Li, Yaping","Shang, Jingzhou","Zeng, Lingjun","Zhao, Jie","Guan, Chaokun","Liu, Qiaomei","Chen, Haifeng","Gong, Wei","Huang, Xin","Zhang, Yu-Jiao","Liu, Jianguang","Dong, Xiaoyan","Zheng, Wen","Nie, Shaoping","Li, Dongsheng","32458459"],"abstract":["OBJECTIVE: This retrospective study was designed to explore whether neutrophil to lymphocyte ratio (NLR) is a prognostic factor in patients with coronavirus disease 2019 (covid-19). METHODS: A cohort of patients with covid-19 admitted to the Tongren Hospital of Wuhan University from January 11, 2020 to March 3, 2020 was retrospectively analyzed. Patients with hematologic malignancy were excluded. The NLR was calculated by dividing the neutrophil count by the lymphocyte count. NLR values were measured at the time of admission. The primary outcome was all-cause in-hospital mortality. A multivariate logistic analysis was performed. RESULTS: 1004 patients with covid-19 were included in this study. The mortality rate was 4.0% (40 cases). The median age of nonsurvivors (68 years) was significantly older than survivors (62 years). Male sex was more predominant in nonsurvival group (27; 67.5%) than in the survival group (466; 48.3%). NLR value of nonsurvival group (median 49.06, IQR 25.71-69.70) was higher than that of survival group (median 4.11, IQR 2.44-8.12, P < 0.001). In multivariate logistic regression analysis, after adjusting for confounding factors, NLR > 11.75 was significantly correlated with all-cause in-hospital mortality (OR = 44.351, 95% CI = 4.627-425.088). CONCLUSIONS: These results suggest that the NLR at hospital admission is associated in-hospital mortality among patients with covid-19. Therefore, the NLR appears to be a significant prognostic biomarker of outcomes in critically ill patients with covid-19. However, further investigation is needed to validate this relationship with data collected prospectively. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Yan, Xisheng","Li, Fen","Wang, Xiao","Yan, Jie","Zhu, Fen","Tang, Shifan","Deng, Yingzhong","Wang, Hua","Chen, Rui","Yu, Zhili","Li, Yaping","Shang, Jingzhou","Zeng, Lingjun","Zhao, Jie","Guan, Chaokun","Liu, Qiaomei","Chen, Haifeng","Gong, Wei","Huang, Xin","Zhang, Yu-Jiao","Liu, Jianguang","Dong, Xiaoyan","Zheng, Wen","Nie, Shaoping","Li, Dongsheng"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32458459","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26061","keywords":["lymphopenia","neutrophils","pneumonia","prognostic","sars-cov-2"],"locations":["neutrophil"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667967698934431744,"score":354.90808}]}